A reduction in TNFR2 signaling has been linked to impaired Treg function, contributing to an increased risk of autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) [34]. The gene discussed is TNFRSF1B; the disease is rheumatoid arthritis.